Standard BioTools Inc.
LAB | NASDAQ
$0.74
-$0.03 (-3.87%)
At close: Sep 21, 2026, 4:00 PM ET
$0.73
-$0.01 (-1.35%)
Pre-market:
Sep 22, 2026, 4:00 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -6.40 | -3.37 | -2.35 | -0.48 | -5.03 | -8.11 |
PEG Ratio | 0.10 | 0.08 | 0.04 | 0 | -0.93 | 0.34 |
PS Ratio | 5.72 | 3.54 | 1.65 | 0.94 | 2.28 | 3.13 |
PB Ratio | 1.15 | 1.31 | -1.18 | -1.12 | 3.14 | 3.11 |
P/FCF Ratio | -5.91 | -4.07 | -3.79 | -0.98 | -5.18 | -15.36 |
P/OCF Ratio | -6.57 | -4.30 | -4.04 | -1.03 | -6.74 | -28.04 |
OCF/S Ratio | -87.13 | -82.24 | -40.71 | -91.24 | -33.74 | -11.16 |
Debt / Equity Ratio | 0.07 | 0.07 | -0.66 | -1.26 | 1.18 | 0.69 |
Quick Ratio | 4.01 | 5.09 | 1.26 | 4.31 | 1.03 | 1.81 |
Current Ratio | 4.19 | 5.70 | 1.45 | 4.81 | 1.45 | 2.17 |
Asset Turnover | 0.15 | 0.28 | 0.33 | 0.25 | 0.47 | 0.43 |
Interest Coverage | -3.59K | -52.85 | -16.77 | -26.83 | -17.65 | -14.29 |
Return on Equity | -17.65% | -29.44% | 50.43% | 233.34% | -62.62% | -38.13% |
Return on Assets | -13.19% | -22.68% | -23.11% | -48.70% | -21.52% | -16.33% |
Return on Invested Capital | -12.21% | -31.71% | -27.59% | -32.47% | -26.65% | -18.29% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 49.86% | 48.31% | 47.44% | 37.83% | 53.13% | 60.32% |
Net Profit Margin | -87.77% | -79.62% | -70.20% | -194.08% | -45.36% | -38.38% |
Pretax Profit Margin | -113.33% | -79.29% | -69.78% | -196.97% | -48.75% | -39.16% |
Operating Profit Margin | -109.34% | -100.46% | -72.03% | -118.64% | -51.66% | -36.94% |
FCF Margin | -96.86% | -87.03% | -43.37% | -95.15% | -43.90% | -20.37% |
EBITDA Margin | -105.11% | -67.73% | -51.21% | -177.21% | -33.90% | -25.05% |
Add to Watchlist
Select watchlists to add or remove LAB